Annexon (ANNX) Stock
Annexon (ANNX) closed at $3.47 on Nov 17, 2026; its Tenet Score is 37 of 100 against 340 Healthcare peers.
34 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $3.47
- Nov 17, 2026
- Market cap
- $733.7M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 2.65 – 7.18
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 37/100
- Weak · 340 Healthcare peers
Industry: Drugs
Annexon Inc scores 37/100. Weak. Quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 37 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| MeiraGTx Holdings plcMGTX | 69 | $854.2M |
| Syndax Pharmaceuticals IncSNDX | 49 | $815.3M |
| Collegium Pharmaceutical IncCOLL | 60 | $790.2M |
| Monte Rosa Therapeutics IncGLUE | 66 | $782.7M |
| Lexicon Pharmaceuticals IncLXRX | 41 | $779.2M |
| Ardelyx IncARDX | 46 | $771.7M |
| Universe Pharmaceuticals INCUPC | 62 | $674.7M |
| Janux Therapeutics IncJANX | 74 | $668.1M |
| Kura Oncology IncKURA | 30 | $651.4M |
| Olema Oncology Inc.OLMA | 56 | $644.8M |
Common questions
What sector and industry is Annexon in?
Annexon is in the Healthcare sector and the Drugs industry.
What is Annexon's Tenet Score?
Annexon's Tenet Score is 37 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




